NEW YORK (GenomeWeb News) – RayBiotech today announced a deal with Norwegian organizations for the use of RayBiotech's antibody arrays for sample analysis services.

The deal, which involves Oslo University Hospital and the University of Oslo, provides for the use of RayBiotech's array technology for the high-throughput detection and analysis of protein biomarkers in biological samples. Potential biomarkers include cytokines, growth factors, and other secreted factors related to complex diseases, such as cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.